MAPT and breast cancer: Here, we used dimethyl sulfate probing read out by mutational profiling (DMS-MaP) as described previously (Mustoe et al., 2019; Homan et al., 2014) to assess MAPT pre-mRNA and mature mRNA structures in T47D cells, a breast cancer line, and in neuronal SH-SY5Y cells.